Curious to see your top suppliers emissions?
Book a demo for a pilot project
Shanghai Pharmaceuticals
Pharmaceutical Preparation ManufacturingChinaPNK: SHPMY
Last verified 11 months agosphchina.com
Shanghai Pharmaceuticals Holding Co., Ltd., commonly known as Shanghai Pharma or SPH, is a prominent pharmaceutical group headquartered in Shanghai, China. Founded in 1994, it rapidly established itself, listing on the Hong Kong Stock Exchange the same year, followed by the Shanghai Stock Exchange in 2003.
As a leading entity in Pharmaceutical Preparation Manufacturing, Shanghai Pharma operates across the entire pharmaceutical value chain, encompassing R&D, manufacturing, distribution, and retail. The company is committed to R&D-driven innovation, developing high-quality pharmaceutical products and therapeutics.
With a focus on major disease areas including cardiovascular, anti-tumour, and central nervous system, SPH consistently enhances its research capabilities. This comprehensive approach underscores its significant position in the global healthcare sector, delivering essential medicines.
23
DitchCarbon score
-19 vs industry average
Shanghai Pharmaceuticals’s score of 23 is lower than 36% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Shanghai Pharmaceuticals?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very High
Pharmaceutical Preparation Manufacturing is among the most carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Shanghai Pharmaceuticals yet.
Shanghai Pharmaceuticals's reported carbon emissions
Shanghai Pharmaceuticals, a pharmaceutical preparation manufacturing company headquartered in China, currently does not have publicly available carbon emissions data. Therefore, specific details regarding their Scope 1, 2, or 3 emissions, or any associated reduction targets, cannot be provided. Their climate commitments and disclosures are understood to originate from Shanghai Pharmaceuticals Holding Co., Ltd.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Shanghai Pharmaceuticals’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Shanghai Pharmaceuticals yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Shanghai Pharmaceuticals11 months ago
23
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more